Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

Seasonal Influenza Vaccine

This phase II is performed as a multicenter study in elderly subjects. Enrolled subjects received one single IM dose of trivalent subunit inactivated adjuvanted flu vaccine during the vaccination visit, according to the study protocol (follow-up period: until day 22) .

Trial Locations (6)

16132

"Department of Scienze della Salute University of Genova Via Pastore 1", Genova

20052

"Department of malattie infettive Ospedale San Gerardo, via Pergolesi 33", Monza

20127

Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona 20, Milan

66034

"Satellite: ASL Lanciano - Vasto, sede legale Via S Spaventa 37", Lanciano

66100

Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via Dei Vestini

Unknown

"Satellite: Distretto Sanitario di Base di Fossacesia in Via Polidoro-Vasto", Lanciano

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY